Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-12-040671
Filing Date
2012-07-13
Accepted
2012-07-13 20:13:30
Documents
1
Period of Report
2012-07-12

Document Format Files

Seq Description Document Type Size
1 FORM 4 - NARACHI rrd350984.html 4  
1 FORM 4 - NARACHI rrd350984.xml 4 12373
  Complete submission text file 0001181431-12-040671.txt   13797
Mailing Address C/O ADVANCED MAGNETICS, INC. 125 CAMBRIDGEPARK DRIVE, 6TH FLOOR CAMBRIDGE MA 02140
Business Address
NARACHI MICHAEL (Reporting) CIK: 0001380022 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33415 | Film No.: 12962588

Mailing Address 3344 N. TORREY PINES CT. SUITE 200 LA JOLLA CA 92037
Business Address 3344 N. TORREY PINES CT. SUITE 200 LA JOLLA CA 92037 (858) 875-8600
Orexigen Therapeutics, Inc. (Issuer) CIK: 0001382911 (see all company filings)

EIN.: 651178822 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations